Canatu Plc · OMXHEX:CANATU

Canatu — Canatu Oyj A Ord — FY2024 Earnings Presentation

31 slides from Canatu's earnings presentation, Mar 28, 2025

  1. Slide 1: Financial Statements Bulletin January-December 2024

    CANATU Financial Statements Bulletin January-December 2024 Juha Kokkonen, CEO Mikko Vesterinen, CFO March 28, 2025

  2. Slide 2: Disclaimer

    Disclaimer Notice Canatu Pic (the "Company’)has prepared this presentation for information purposes only. For the purposes of this disclaimer, ‘presentation’ means these slides, their contents or any part of them, any oral presentation, any question or answer session and any written or oral material

  3. Slide 3: Agenda

    Agenda * Canatu in brief * Highlights ° Financial review * Long-term financial targets * 2025 Outlook * Strategy * Q&A Juha Kokkonen Mikko Vesterinen CEO CFO CANATU

  4. Slide 4: Canatu is a rapidly growing deep tech company

    Canatu is a rapidly growing deep tech company creating advanced carbon nanotubes for industry-transforming products Founded in 2004 Listed on Nasdaq First North GM in September 2024 Differentiated IPR-protected technology Proven mass production since 2015 Customer relationships with global leaders 1

  5. Slide 5: Canatu in brief: high-growth markets are transforming

    Canatu in brief Canatu’s current high-growth markets are undergoing transformation Semiconductor Automotive Medical diagnostics ul / Semiconductor is experiencing Automotive is seeking to shift into Medical diagnostics aims to Py 0, growing demand for advanced PS 0, assisted and autonomous driving o

  6. Slide 6: Canatu's asset-light business model enables scalability

    Canatu in brief Canatu’s asset-light business model enables scalability CNT product sales Semiconductor products Automotive products Medical diagnostics Non-recurring revenue Recurring revenue First reactor shipments in mass production since _in mass production since under development from reactor s

  7. Slide 7: Reactor purchase order to mass production process

    PURCHASE ASSEMBLY AND FACTORY INSTALLATION AND SITE PILOT AND RISK ORDER ACCEPTANCE TEST (FAT) ACCEPTANCE TEST (SAT) MASS PRODUCTION AT CANATU AT CUSTOMER REACTOR DESIGN AND REACTOR DISASSEBLY AND READY CNT PELLICLE HIGH-VOLUME MANUFACTURING SHIPPING PRODUCT AND MASS PRODUCTION MANUFACTURING LINE AC

  8. Slide 8: Highlights 2024

    Highlights 2024 i Canatu was listed on the Nasdaq First North Growth Market Finland on 17 September 2024 through the combination with Lifeline SPAC I. CANATU We sustained strong top-line growth, delivering revenue of 22.0ME (13.6). The revenue growth supported a strong gross profit which grew by 43.

  9. Slide 9: Financial review

    Financial review Mikko Vesterinen, CFO CANATU

  10. Slide 10: Canatu sustained strong revenue growth

    Canatu sustained strong revenue growth REVENUE M€ 22,0 13,6 8,4 5,5 = a 2020 2021 2022 2023 2024 (pro forma) CANATU Financial review

  11. Slide 11: Key figures (pro forma)

    Key figures (pro forma) REVENUE GROWTH GROSS PROFIT GROSS MARGIN 62.1% 13.8me 62.5% (62.1%) (9.6M €) (70.9%) ADJUSTED EBIT MARGIN CAPEX -21.9% 5.Ome (-10.0%) (4.7M€) PATENTS & APPLICATIONS EMPLOYEES (FTE) 213 123 CANATU Financial Review Revenue and gross profit growth driven by the strong developmen

  12. Slide 12: Revenue by business unit (pro forma)

    Financial review Revenue by business unit (pro forma) SEMICONDUCTOR AUTOMOTIVE MEDICAL DIAGNOSTICS ¢ Semiconductor: growth driven by the shipment of the REVENUE REVENUE REVENUE first two CNT100 SEMI reactors and steady 19. 7me 2. 3mue 6) Ome development in the inspection filters e Automotive: slight

  13. Slide 13: Long-term financial targets for 2027

    Long-term financial targets for 2027 Canatu’s long-term financial targets are: + Revenue over EUR 100 ME + EBIT margin (adjusted for goodwill amortization under Finnish Accounting Standards) over 30% Relative contribution: * Semiconductor: Large * Automotive: Medium * Medical diagnostics: Limited +

  14. Slide 14: Targets

    Targets Long-term financial targets are grounded on the current focus industries and a more conservative market scenario Canatu’s long-term financial Reaching the targets may Long-term financial targets are targets are grounded on: require: not predicated on upside ¢ Existing customer relationships

  15. Slide 15: 2025 Outlook

    2025 Outlook Juha Kokkonen, CEO CANATU

  16. Slide 16: 2025 Outlook

    2025 Outlook 2025 Outlook Long-term potential remains unchanged No guidance issued * Canatusees that the company’s long-term potential in the three * In accordance with its disclosure business focus areas—Semiconductor, Automotive, and Medical policy, Canatu does not issue any Diagnostics—has remain

  17. Slide 17: 2025 Outlook: Semiconductor and Automotive

    2025 Outlook 2025 Outlook SEMICONDUCTOR AUTOMOTIVE Largest revenue contributor in 2025 + Inthe near-term, Canatu expects that royalty and consumable revenue from existing CNT100 SEMI reactor customers will depend on three key steps: i. the customers need to complete the final Site Acceptance Tests (

  18. Slide 18: Canatu's strategy 2025-2027

    Canatu's strategy 2025-2027 Our vision is to create the most advanced carbon nanotubes for industry-transforming products Become a leader in CNT pellicle membranes, inspection membranes, optical filters, and related CNT TS manufacturing equipment for EUV technology. Revenue: 100 me | Develop medical

  19. Slide 19: • • • • 1000 • 2024E 2030E 2024E 2030E •

    • 2 000 • • • 1000 • 60 2024E 2030E 2024E 2030E •

  20. Slide 20: EURm 2024E 2030E

    • EURm • 600 • • • 150 15 2024E 2030E

  21. Slide 21: Accelerating technology and business development for medical diagnostics

    Accelerating technology and business development for medical diagnostics ¢ In 2024, Canatu had no medical diagnostics products in mass production, as this domain is still emerging e Key market drivers include the shift from centralized to point- of-care (POC) testing and the increasing demand for hi

  22. Slide 22: Canatu launches Carbon Age program with EUR 10M funding

    Canatu launches Carbon Age program for which it has Strategy received EUR 10M funding granted by Business Finland CURRENT NEXT-PHASE CORE BUSINESS GROWTH AVENUES. Biosensors CNT pellicle membranes y (medical diagnostics) (semicon) ; : EUV optical filters ADAS heaters (semicon) (automotive) > LL Sola

  23. Slide 23: Investments in 2025

    Investments In 2025, we will make significant investments to support the existing product portfolio and develop new businesses e In 2025, Canatu continues to invest to support its existing 1 2 3 product portfolio and develop new businesses and . Developing updated Developing optical Accelerating med

  24. Slide 24: Organization

    Organization Changes in management team apani Salmine' ¢ Tapani Salminen (M.Sc.Tech) has been appointed as the new Chief Operations Officer. Salminen will be responsible for organizing operations for rapid scaling, overseeing production, supply chain management, facilities, quality, and IT. He will

  25. Slide 25: Canatu to expand with new production facility in Finland

    Canatu to expand with new production facility in Finland, doubling its premises ¢ Canatu is expanding with a new facility next to its current HQ and factory in Vantaa, Finland. « Expansion is driven by the need for more space to accommodate long-term growth plans. ¢ The new facility will provide the

  26. Slide 26: We are moving full speed ahead

    We are moving full soeed ahead Canatu has solid investment andj growth strategy towards 2027] ladd with its CNT solution profitability in 1 2024 S CANATU

  27. Slide 27: Q&A

    Q&A CANATU

  28. Slide 28: Thank you

    Thank you for your interest + May 15, 2025: Annual General Meeting * Week 16, 2025: Annual Report * Aug 29, 2025: Half-Year Report CANATU

  29. Slide 29: Unaudited pro forma income statement

    Unaudited pro forma income statement EUR million 1-12/2024 1-12/2023 Change % REVENUE 22.0 13.6 62.1% Change in inventory of finished and work-in- progress products 0.5 0.2 205.8% Other operating income 1.1 2.9 -59.8% Materials and external services -8.1 -3.5 -129.5% Personnel expenses -11.1 -8.4 -3

  30. Slide 30: Balance sheet

    Canatu Plc (former Canatu Plc (former Canatu Lifeline SPAC I) Canatu Lifeline SPAC I) EUR million 31.12.2024 31.12.2023 EUR million 31.12.2024 31.12.2023 EQUITY ASSETS Share capital 0.1 0.1 NON-CURRENT ASSETS Reserve for invested unrestricted equity 117.8 104.3 Goodwill 4.5 – Translation differences

  31. Slide 31: Cash flow statement

    EUR million Canatu 1-12/2024 Canatu 1-12/2023 EUR million Canatu 1-12/2024 Canatu 1-12/2023 Cash flow from investing activities Cash flow from operating activities Investments in tangible and intangible assets -5.0 -4.7 Profit (loss) before income taxes -1.7 -1.6 Acquisition of subsidiary shares net

Canatu Oyj A Ord — FY2024 Earnings Presentation on 6ix